0000899243-20-024894.txt : 20200911
0000899243-20-024894.hdr.sgml : 20200911
20200911160526
ACCESSION NUMBER: 0000899243-20-024894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turtle Cameron
CENTRAL INDEX KEY: 0001758363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 201170969
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-10
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001758363
Turtle Cameron
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2000
SAN FRANCISCO
CA
94104
0
1
0
0
Chief Business Officer
Common Stock
2020-09-10
4
M
0
2500
17.00
A
73031
D
Common Stock
2020-09-10
4
S
0
2500
47.00
D
70531
D
Stock Option (Right to Buy)
17.00
2020-09-10
4
M
0
2500
0.00
D
2028-06-20
Common Stock
2500
16420
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2019.
The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 18, 2018, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
/s/ Franco Valle, as Attorney-in-Fact
2020-09-11